Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TVTX : 18.25 (+2.18%)
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

TVTX : 18.25 (+2.18%)
3 Under-the-Radar Healthcare Companies

While established healthcare firms are among the most stable stocks in the sector, up-and-coming companies can offer the potential for greater gains.

NTRA : 169.49 (+0.96%)
TVTX : 18.25 (+2.18%)
XLV : 143.24 (+0.25%)
MCK : 626.20 (+0.81%)
UNH : 601.21 (+0.12%)
THC : 146.42 (-3.57%)
Travere Therapeutics Announces Pricing of Public Offering of Common Stock

TVTX : 18.25 (+2.18%)
Travere Therapeutics Announces Proposed Public Offering of Common Stock

TVTX : 18.25 (+2.18%)
Travere Therapeutics to Present at Upcoming Investor Conferences

TVTX : 18.25 (+2.18%)
Travere: Q3 Earnings Snapshot

Travere: Q3 Earnings Snapshot

TVTX : 18.25 (+2.18%)
Travere Therapeutics Reports Third Quarter 2024 Financial Results

TVTX : 18.25 (+2.18%)
Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024

TVTX : 18.25 (+2.18%)
Travere Therapeutics to Report Third Quarter 2024 Financial Results

TVTX : 18.25 (+2.18%)

Barchart Exclusives

3 Ways to Invest in Small-Cap Stocks Now
With small-cap stocks surging in response to Donald Trump's re-election and the Federal Reserve's rate cut, investors can tap into this momentum through three distinct ETFs: VBK, DWAS, and UWM, each offering a unique approach to capturing the growth potential of small-cap stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar